APAndre C. Pimentel C. Pimentel

Andre C. Pimentel C. Pimentel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andre C. Pimentel C. Pimentel has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Distinct photooxidation-induced cell death pathways lead to selective killing of human breast cancer cells

    by Ancély F. dos Santos, Alex Inague, Gabriela S. Arini, Letícia F. Terra, Rosangela A.M. Wailemann, Andre C. Pimentel C. Pimentel, Marcos Y. Yoshinaga, Ricardo R. Silva R. Silva, Divinomar Severino, Daria Raquel Q. de Almeida, et al.

    Lack of effective treatments for aggressive breast cancer is still a major global health problem. We previously reported that Photodynamic Therapy using Methylene Blue as photosensitizer (MB-PDT) massively kills metastatic human breast cancer, marginally affecting healthy cells. In this study we aimed to unveil the molecular mechanisms behind MB-PDT effectiveness. Through lipidomic and biochemical approaches we demonstrated that MB-PDT efficiency and specificity relies on polyunsaturated fatty acids-enriched membranes and on the better capacity to deal with photooxidative damage displayed by non-tumorigenic cells. We found out that, in tumorigenic cells, lysosome membrane permeabilization is accompanied by ferroptosis and/or necroptosis. Our results broadened the understanding of MB-PDT-induced photooxidation mechanisms and specificity in breast cancer cells. Therefore, we demonstrated that efficient approaches could be designed on the basis of lipid composition and metabolic features for hard-to-treat cancers. The results further reinforce MB-PDT as a therapeutic strategy for highly aggressive human breast cancer cells.